China Foods Holdings Ltd.

What they do

CFOO operates through wholly owned subsidiary Guangzhou Xiao Xiang Health Industry Company Limited, a China limited liability company formed March 8, 2017, held via Alpha Wellness (HK) Limited and Elite Creation Group. The company develops, markets and distributes healthcare products and consultation services in China, working with licensed healthcare food factories. Distribution runs through sales agents and e-commerce and social media platforms. Products include meal replacements and snacks, special health foods, supplements, skincare and Bordeaux wine sourced from France.

Revenue drivers

• Nutrition Catering Series — Meal replacement and healthy snacks marketed under the Jasmine Beauty brand; sold through sales agents and online channels.
• Special Health Food Series — Products such as Power Centinent positioned to support an active lifestyle and enhance immunity.
• Health Supplement Series — Functional fruit beverages and supplements such as Fuli Fruit Juice containing resveratrol, anthocyanin and superoxide enzyme.
• Wine and Skincare — Bordeaux wine imported from France (Ame de Purete, sourced via a distribution agreement with Shenzhen Guisheng Supply Chain Co., Ltd.) and skincare items such as facial masks, part of a stated diversification effort.

Recent performance

Annual revenue was $361,116 in 2021, $354,096 in 2022, $158,475 in 2023, $233,339 in 2024 and $327,871 in 2025, with net losses each year ($398,672 in 2025). Quarterly revenue fell to $253 in the March 2026 quarter and $2 in the quarter ended June 30, 2026, versus $142,214 in the June 2025 quarter. For the six months ended June 30, 2026 revenue was $255 versus $142,255 a year earlier, and the June 2026 quarter net loss was $63,750 against $97,352. At June 30, 2026 the company reported total assets of $215,549, total liabilities of $1.6M, negative shareholder equity of $1.4M and cash of $15,923. Operating cash flow was negative in every year shown, including -$389,251 in 2025.

Strategy

Management says it develops and distributes customized health and wellness products and consultation services in China. It works with licensed healthcare food factories and distributes through sales agents plus e-commerce and social media. The 10-K states an intent to expand beyond wine into beauty products, particularly skincare such as facial masks. The 10-Q says the company is monitoring trade tensions and tariffs and implementing supplier diversification, local sourcing and logistics optimization to mitigate supply chain and pricing risks. No specific capital investment or acquisition program is disclosed in the excerpts provided.

Risks

• Revenue collapse — Quarterly revenue fell from $142,214 in the June 2025 quarter to $253 and $2 in the March and June 2026 quarters, leaving little operating cash generation.
• Negative equity and thin liquidity — At June 30, 2026 total liabilities of $1.6M exceeded total assets of $215,549, leaving shareholder equity of -$1.4M and cash of $15,923.
• China legal and regulatory uncertainty — The 10-K states that Chinese rules can change quickly with little advance notice and that the Chinese government may intervene in or influence the company's operations at any time.
• Supply chain and tariff exposure — The 10-Q cites recent trade tensions and high tariffs as potential risks to the supply chain and pricing of products, including imported French wine sourced from a third-party distributor.

Outlook

The 10-K says China's Great Health Industry is positioned for sustained structural growth into 2026, moving from basic healthcare needs toward more comprehensive services. The 10-Q says the company is implementing supplier diversification, local sourcing and logistics optimization to address trade and tariff pressures. Management provides no specific revenue or earnings guidance in the excerpts. Actual results to date show revenue approaching zero in the most recent quarter reported.